The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study.
Khalaf KridinNoor MruwatDiamant ThaciRalf J LudwigPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases